Axonal transport deficits and neurodegenerative diseases
The DOI matches its Crossref record; 179 of the 180 references it cites were found in a registry or an index.
Abstract
The intracellular transport of organelles along an axon is crucial for the maintenance and function of a neuron. Anterograde axonal transport has a role in supplying proteins and lipids to the distal synapse and mitochondria for local energy requirements, whereas retrograde transport is involved in the clearance of misfolded and aggregated proteins from the axon and the intracellular transport of distal trophic signals to the soma. Axonal transport can be affected by alterations to various components of the transport machinery. Here, we review the current state of knowledge about axonal transport defects that might contribute to the pathogenesis of particular neurodegenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, tau is also associated with mitochondrial calcium imbalance, and due to the critical role of tau in microtubule structure and function, its abnormal phosphorylation and aggregation may adversely affect mitochondrial axonal transport, impacting local metabolic needs and overall neuronal function.296,297”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [297]
Citations
Cites
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L.-H. (1999) · Nature · doi:10.1038/45159 · Cited by 1,545
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,177
Cited by
Items 201–300 of 753
Mitophagy Modulation, a New Player in the Race against ALS
Madruga, E., Maestro, I., & Martínez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020740 · Cited by 44
“Many pathological pathways involved in ALS can be related to mitochondrial defects one way or another: typical axonal transport defects in ALS impair mitochondria distribution [20]; altered Ca2+ homeostasis due to glutamate hyperexcitability involves mitochondria as the major Ca2+ storage site [21]; defective mitochon…”
BackgroundOverexpression of KLC2 due to a homozygous deletion in the non-coding region causes SPOAN syndrome
Melo, U. S., Macedo-Souza, L. I., Figueiredo, T., Muotri, A. R., Gleeson, J. G., Coux, G., Armas, P., Calcaterra, N. B., Kitajima, J. P., Amorim, S., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv388 · Cited by 43
“tive diseases show impairment in axonal transport (13,14) and some kinesins heavy chains (KIF5A, KIF1A and KIF1C) have been associated with HSP (15–18).”
BackgroundPediaditakis, I., Efstathopoulos, P., Prousis, K. C., Zervoú, M., Arévalo, J. C., Alexaki, V. I., Nikoletopoulou, V., Karagianni, E., Potamitis, C., Tavernarakis, N., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.007 · Cited by 46
“It was recently reported that NGF has a beneficial effect on b-amyloid-mediated neurotoxicity and tau-phosphorylation, two major factors in the pathophysiology of Alzheimer's disease (Matrone et al., 2008; Zhang et al., 2010).”
InfluentialOverexpression of Kinesin Superfamily Motor Proteins in Alzheimer’s Disease
Hares, K. M., Miners, J. S., Cook, A. J., Rice, C. M., Scolding, N. J., Love, S., & Wilkins, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170094 · Cited by 49
“We have found increased KIF gene and protein expression in AD, and significant inverse correlations between KIF5A expression and A (cid:2) PP and soluble A (cid:2) in AD.”
Microtubule-targeting agents and neurodegeneration
Boiarska, Z., & Passarella, D. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.033 · Cited by 48
Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases
Shahsavani, N., Kataria, H., & Karimi‐Abdolrezaee, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166117 · Cited by 45
Theunissen, F., West, P. K., Brennan, S. E., Petrović, B., Hooshmand, K., Akkari, P. A., Keon, M., & Guennewig, B. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00272-z · Cited by 50
“On the other hand, other mutations in the head and rod domains of NEFL are associated with CMT type 1 and 2 [41, 42].”
BackgroundInfluentialThe Role of Axonal Transport in Glaucoma
Dias, M. S., Luo, X., Ribas, V. T., Petrs‐Silva, H., & Koch, J. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073935 · Cited by 51
“of transported molecules in the affected region [79].”
BackgroundFeng, F., Zhang, M., Yang, C., Heng, X., & Wu, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109441 · Cited by 46
Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)
Suzuki, N., Akiyama, T., Warita, H., & Aoki, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00194 · Cited by 48
“Impaired cargo transport in axons can cause neurodegeneration (Millecamps and Julien, 2013).”
BackgroundGan, K. J., & Silverman, M. A. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-12-1612 · Cited by 41
“Impaired fast axonal transport (FAT) of organelles correlates with early stages of Alzheimer’s disease (AD) progression and is observed before cell death (Goldstein, 2012; Millecamps and Julien, 2013).”
Ho, Y., Au, N. P. B., Wong, K., Chan, C. T., Kwok, W., Law, G., Tang, K.-K., Wong, W., Ma, C. H. E., & Lam, M. H. (2014) · Chemical Communications · doi:10.1039/c3cc48934e · Cited by 41
Kar, A. N., Lee, S. J., & Twiss, J. L. (2017) · The Neuroscientist · doi:10.1177/1073858417712668 · Cited by 50
C9ORF72 expression and cellular localization over mouse development
Atkinson, R. A. K., Fernández-Martos, C. M., Atkin, J. D., Vickers, J. C., & King, A. E. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0238-7 · Cited by 51
“There are a number of vesicles known to be present in axons including those supplying the synapse, those involved in membrane trafficking and axon outgrowth, and vesicles containing RNA and signaling vesicles [21].”
BackgroundStructural Basis for Induction of Peripheral Neuropathy by Microtubule-Targeting Cancer Drugs
Smith, J. A., Slusher, B. S., Wozniak, K. M., Farah, M. H., Smiyun, G., Wilson, L., Feinstein, S. C., & Jordan, M. A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3116 · Cited by 44
Retrograde transport of Akt by a neuronal Rab5-APPL1 endosome
Goto‐Silva, L., McShane, M. P., Salinas, S., Kalaidzidis, Y. L., Schiavo, G., & Zerial, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-38637-0 · Cited by 36
“Rabankyrin-5, Rabenosyn-5 and EEA1 all contain a FYVE domain which, by binding to phosphatidylinositol 3-phosphate (PI(3)P) and, together with binding to Rab5, supports recruitment to PI(3)P-positive early endosomes14,29,47.”
BackgroundTubulin polyglutamylation, a regulator of microtubule functions, can cause neurodegeneration
Bodakuntla, S., Janke, C., & Magiera, M. M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135656 · Cited by 46
Molecular and cellular mechanisms of spastin in neural development and disease (Review)
Liu, Q., Zhang, G., Ji, Z., & Lin, H. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5051 · Cited by 50
“Axon transport is essential for regulating axon composition, neural development, mainte‐ nance and survival (110,111).”
BackgroundMechanistic and therapeutic role of Drp1 in the pathogenesis of Alzheimer's disease
Bera, A., Lavanya, G., Reshmi, R., Dev, K., & Kumar, R. K. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15611 · Cited by 44
The Role of Spastin in Axon Biology
Costa, A. C., & Sousa, M. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.934522 · Cited by 45
Methodological advances in imaging intravital axonal transport
Sleigh, J. N., Vagnoni, A., Twelvetrees, A. E., & Schiavo, G. (2017) · F1000Research · doi:10.12688/f1000research.10433.1 · Cited by 41
p27Kip1 Modulates Axonal Transport by Regulating α-Tubulin Acetyltransferase 1 Stability
Morelli, G., Even, A., Gladwyn-Ng, I., Le Bail, R., Shilian, M., Godin, J. D., Peyre, E., Hassan, B. A., Besson, A., Rigo, J.-M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.083 · Cited by 39
“Impaired axonal transport is a common hallmark of many neurodevelopmental and neurodegenerative disorders (Gauthier et al., 2004; Godena et al., 2014; Lefler et al., 2015; Millecamps and Julien, 2013), and reduced levels of p27 have been detected in motoneurons from animal models of sporadic amyotrophic lateral sclero…”
BackgroundInfluentialMicrotubule Destabilization Paves the Way to Parkinson’s Disease
Cartelli, D., & Cappelletti, G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0188-5 · Cited by 48
“In addition, impairment of axonal transport, which strictly depends on the MT system, is a common defect in many neurodegenerative diseases [4], and direct evidence supporting the involvement of the MTs in neurodegenerative disorders came from genetic studies which identified mutations in various tubulin family member…”
BackgroundPearn, M. L., Schilling, J. M., Jian, M., Egawa, J., Wu, C., Mandyam, C. D., Fannon, M. J., Nguyen, U. T. T., Bertoglio, J. H., Kodama, M., et al. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2017.12.033 · Cited by 39
Hannan, S. B., Dräger, N. M., Rasse, T. M., Voigt, A., & Jahn, T. R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13532 · Cited by 38
Role of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review
Wang, Q., Xue, H., Yue, Y., Hao, S., Huang, S., & Zhang, Z. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1014251 · Cited by 38
“Besides, the strict control of mitochondrial size, number, and distribution is crucial for neurons (Millecamps and Julien, 2013; Schönfeld and Reiser, 2013; Stavoe and Holzbaur, 2019).”
BackgroundDebaisieux, S., Encheva, V., Chakravarty, P., Snijders, A. P., & Schiavo, G. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.051649 · Cited by 38
“degeneration may be linked to axonal transport deficits caused by mutations in genes coding for proteins involved in organelle trafficking, such as molecular motors, motor adaptors and regulators, and cytoskeletal components (7, 8, 49).”
Axonal transport deficits in multiple sclerosis: spiraling into the abyss
van den Berg, R., Hoogenraad, C. C., & Hintzen, R. Q. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1697-7 · Cited by 38
“There is substantial evidence that such a loop could play a role in a large variety of neurodegenerative disorders (reviewed in [59, 103]).”
BackgroundCarmichael, K., Sullivan, B. T., Lopez, E., Sun, L., & Cai, H. (2021) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.07 · Cited by 52
Axonal transport rate decreased at the onset of optic neuritis in EAE mice
Lin, T., Kim, J. H., Pérez‐Torres, C. J., Chiang, C., Trinkaus, K. M., Cross, A. H., & Song, S. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.06.009 · Cited by 39
“1, 3 and 4) indicating defective fast axonal transport at the onset of ON (Millecamps and Julien, 2013).”
Belosludtseva, N. V., Matveeva, L. A., & Belosludtsev, K. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316833 · Cited by 43
Chazeau, A., Katrukha, E. A., Hoogenraad, C. C., & Kapitein, L. C. (2015) · Methods in cell biology · doi:10.1016/bs.mcb.2015.06.017 · Cited by 39
“…not surprising that impairment in intracellular transport has been linked to neuronal and synaptic malfunctioning and certain neurodegenerative diseases such as Alzheimer’s disease, Huntington’s disease and Amyotrophic lateral sclerosis (Encalada & Goldstein, 2014; Millecamps & Julien, 2013).”
Milde, S., & Coleman, M. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582338 · Cited by 45
“Additionally, a drop in the supply of NMNAT2 from neuronal cell bodies into axons could contribute to axon degeneration in neurodegenerative diseases, where axonal transport has been shown to be impaired at an early stage (3).”
BackgroundNaftelberg, S., Abramovitch, Z., Gluska, S., Yannai, S., Joshi, Y., Donyo, M., Ben‐Yaakov, K., Gradus, T., Zonszain, J., Farhy, C., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006486 · Cited by 40
Gicking, A. M., Ma, T.-C., Feng, Q., Jiang, R., Badieyan, S., Cianfrocco, M. A., & Hancock, W. O. (2022) · eLife · doi:10.7554/elife.82228 · Cited by 35
Nanometer-resolution tracking of single cargo reveals dynein motor mechanisms
Peng, C. S., Zhang, Y., Liu, Q., Marti, G. E., Huang, Y. A., Südhof, T. C., Cui, B., & Chu, S. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01694-2 · Cited by 41
“Dysregulation of axonal transport is thought to lead to neurodegenerative disorders 11 , and robust transport relies ultimately on the fundamental biophysical properties of these motors.”
Crowd Control: Effects of Physical Crowding on Cargo Movement in Healthy and Diseased Neurons
Sabharwal, V., & Koushika, S. P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00470 · Cited by 36
Taran, A., Belikova, L. D., Lagarkova, M. A., & Alieva, I. B. (2020) · Cells · doi:10.3390/cells9061514 · Cited by 40
“Axonal transport disorders are key pathological events contributing to neurodegeneration: polyglutamine diseases, hereditary spastic paraplegia, Charcot-Marie-Tooth disease, amyotrophic lateral sclerosis, and Parkinson’s disease [164].”
BackgroundGriffioen, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713243 · Cited by 37
New insights into mRNA trafficking in axons
Gumy, L. F., Katrukha, E. A., Kapitein, L. C., & Hoogenraad, C. C. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22121 · Cited by 40
Severe Neurodegeneration with Impaired Autophagy Mechanism Triggered by Ostm1 Deficiency
Héraud, C., Griffiths, A., Pandruvada, S. N. M., Kilimann, M. W., Pata, M., & Vacher, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537233 · Cited by 39
Koon, A. C., & Chan, H. Y. E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00070 · Cited by 37
“Despite some of these identified genes play a role in RNA metabolism and axonal trafficking (Strong, 2010; Ikenaka et al., 2012; Millecamps and Julien, 2013; Droppelmann et al., 2014), most of them apparently do not function in the same molecular pathway, complicating the underlying mechanisms of…”
BackgroundNeuron‐targeted caveolin‐1 improves neuromuscular function and extends survival in SOD1 G93A mice
Sawada, A., Wang, S., Jian, M., Leem, J. S., Wackerbarth, J., Egawa, J., Schilling, J. M., Platoshyn, O., Zemljic‐Harpf, A. E., Roth, D. M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802652rr · Cited by 36
Mórotz, G. M., Glennon, E. B. C., Greig, J., Lau, D. H. W., Bhembre, N., Mattedi, F., Muschalik, N., Noble, W. J., Vagnoni, A., & Miller, C. C. J. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0857-5 · Cited by 35
Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma
Breen, K., Anderson, S., Steele, M. R., Calkins, D. J., Bosco, A., & Vetter, M. L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00526 · Cited by 39
“Decline in axonal transport is an early and prevalent feature of many forms of neurodegeneration, including glaucoma, generally preceding signs of structural axon degeneration (Pease et al., 2000; Quigley et al., 2000; De Vos et al., 2008; Soto et al., 2008; Crish et al., 2010, 2013; Chidlow et al., 2011; Millecamps a…”
Lim, S. M., van den Ham, H., Oduber, M., Martina, E., Zaaraoui‐Boutahar, F., Roose, J. M., van IJcken, W. F. J., Osterhaus, A. D. M. E., Andeweg, A. C., Koraka, P., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01556 · Cited by 37
“, 2010), axonal transport deficits (Millecamps and Julien, 2013), neuronal cell cycle induction (Wang et al.”
BackgroundSaito, A., & Cavalli, V. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r115.052753 · Cited by 35
Tasnim, A., Rammelkamp, Z., Slusher, A. B., Wozniak, K. M., Slusher, B. S., & Farah, M. H. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0285-4 · Cited by 34
“Microtubuledependent transport is critical for axonal function and health, both in the central and peripheral nervous systems; as such, disruption of axonal transport is implicated in various central nervous system disorders and peripheral neuropathies [21].”
A role for the GDAP1 gene in the molecular pathogenesis of Charcot-Marie-Tooth disease
Rzepnikowska, W., & Kochański, A. (2018) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2018-002 · Cited by 34
Axonal spheroids in neurodegeneration
Yu, Y., Hunter-Chang, S., Stepanova, E., & Deppmann, C. D. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103679 · Cited by 41
Chowdary, P. D., Che, D. L., Kaplan, L., Chen, O., Pu, K., Bawendi, M. G., & Cui, B. (2015) · Scientific Reports · doi:10.1038/srep18059 · Cited by 37
Edwards, S. L., Morrison, L. M., Yorks, R. M., Hoover, C. M., Boominathan, S., & Miller, K. G. (2015) · Genetics · doi:10.1534/genetics.115.177345 · Cited by 34
“…in the axonal transport machinery with neurodegenerative disorders in mice and humans underscores the importance of a properly functioning transport system for the long-term viability of neurons (Holzbaur 2004; El-Kadi et al. 2007; De Vos et al. 2008; Millecamps and Julien 2013; Maday et al. 2014).”
BackgroundReduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis
Hares, K. M., Kemp, K. C., Rice, C. M., Gray, E., Scolding, N. J., & Wilkins, A. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513508836 · Cited by 39
Growing synergy of nanodiamonds in neurodegenerative interventions
Saraf, J., Kalia, K., Bhattacharya, P., & Tekade, R. K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.10.012 · Cited by 35
Fritsche, L., Teuber‐Hanselmann, S., Soub, D., Harnisch, K. J., Mairinger, F. D., & Junker, A. (2019) · Brain Pathology · doi:10.1111/bpa.12800 · Cited by 36
“Other neurological diseases including Alzheimer’s disease (72), amyotrophic lateral sclerosis (9) and Huntington’s disease (48) also exhibit axonal transport disorders that might represent a mechanism leading to neurodegenerative processes (18, 61, 62).”
BackgroundAxonal mRNA translation in neurological disorders
Lin, J. Q., van Tartwijk, F. W., & Holt, C. E. (2020) · RNA Biology · doi:10.1080/15476286.2020.1822638 · Cited by 36
“of axonal transport is closely associated with multiple neurological disorders [85,86,87], as are structural and functional”
BackgroundWakhloo, D., Mahajani, S. U., Oberhauser, J., & Madira, A. E. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.336138 · Cited by 42
“Axonal degeneration has been identified as a precursor to neuronal death in a number of neurological disorders (Millecamps and Julien, 2013; Grosch et al., 2016; Tagliaferro and Burke, 2016).”
McIntosh, B. B., Holzbaur, E. L. F., & Ostap, E. M. (2015) · Current Biology · doi:10.1016/j.cub.2014.12.008 · Cited by 33
“This transport is essential for normal cellular function, as mutations in either the motors or their adaptors contribute to diseases, including neurodegeneration [13] and sensory and metabolic disorders [14, 15].”
Kallianpur, A. R., Jia, P., Ellis, R. J., Zhao, Z., Bloss, C. S., Wen, W., Marra, C. M., Hulgan, T., Simpson, D. M., Morgello, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103123 · Cited by 34
Engineered kinesin motor proteins amenable to small-molecule inhibition
Engelke, M. F., Winding, M., Yue, Y., Shastry, S., Teloni, F., Reddy, S., Blasius, T. L., Soppina, P., Hancock, W. O., Gelfand, V. I., et al. (2016) · Nature Communications · doi:10.1038/ncomms11159 · Cited by 39
“Golgi-targeting of WT, TC-tagged, and DmrB-tagged KIF5C(1-559) motors in the absence of any inhibitor resulted in a dispersed Golgi phenotype ( Fig.”
BackgroundMethodInfluentialZuo, F., Xiong, F., Wang, X., Li, X., Wang, R., Ge, W., & Bao, X. (2017) · Stem Cells · doi:10.1002/stem.2616 · Cited by 35
Pathological classification of equine recurrent laryngeal neuropathy
Draper, A. C. E., & Piercy, R. J. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15142 · Cited by 34
The ER ladder is a unique morphological feature of developing mammalian axons
Zamponi, E., Meehl, J. B., & Voeltz, G. K. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.05.002 · Cited by 32
Yadav, B., Kaur, S., Yadav, A., Verma, H., Kar, S., Sahu, B. K., Pati, K. R., Sarkar, B., Dhiman, M., & Mantha, A. K. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23660 · Cited by 37
Kuznetsov, I. A., & Kuznetsov, A. V. (2018) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2017.0777 · Cited by 37
“This, in turn, leads to phosphorylation of kinesin-1 light chain, which facilitates kinesin-1 detachment from its cargos [64,65].”
BackgroundAxonal swellings and spheroids: a new insight into the pathology of neurocysticercosis
Maza, A. M., Carmen‐Orozco, R. P., Carter, E. C., Dávila‐Villacorta, D. G., Castillo, G., Morales, J. D., Javier Mamani, P., Gavidia, C. M., Alroy, J., Sterling, C. R., et al. (2018) · Brain Pathology · doi:10.1111/bpa.12669 · Cited by 40
“Axonal swellings, which encompass spheroids and smaller varicosities, are emerging as an important early finding in Alzheimer’s disease (38), amyotrophic lateral sclerosis (25), metabolic encephalopathies, multiple sclerosis and other demyelinating diseases (24).”
Hou, M., Shao, Z., Zhang, S., Liu, X., Fan, P., Jiang, M., Zhao, Y., Xiao, R., & Yuan, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04836-3 · Cited by 34
Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review
Yang, X., Ma, Z., Lian, P., Xu, Y. C., & Cao, X. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1172197 · Cited by 36
Siebert, M., Böhme, M. A., Driller, J. H., Babikir, H. A., Mampell, M. M., Rey, U., Ramesh, N., Matkovic, T., Holton, N., Reddy‐Alla, S., et al. (2015) · eLife · doi:10.7554/elife.06935 · Cited by 33
Atomic force microscopy as an advanced tool in neuroscience
Jembrek, M. J., Šimić, G., Hof, P. R., & Šegota, S. (2015) · Translational Neuroscience · doi:10.1515/tnsci-2015-0011 · Cited by 39
“It is usually preceded by subtle structural and associated functional changes, including synaptic loss, neurite retraction, and disturbance of axonal transport due to microtubule rearrangement and instability [7-10].”
BackgroundChan, K. C., Fan, S., Chan, R. W., Cheng, J. S., Zhou, I. Y., & Wu, E. X. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.12.056 · Cited by 33
“…Wu a,c, ⁎⁎ 4 a Laboratory of Biomedical Imaging and Signal Processing, The University of Hong Kong, Pokfulam, Hong Kong SAR, China 5 b Department of Electrical and Electronic Engineering, The University of Hong Kong, Pokfulam, Hong Kong SAR, China 6 c Department of Anatomy, The University of…”
Brick, D. J., Nethercott, H. E., Montesano, S., Bañuelos, M. G., Stover, A. E., Schutte, S. S., O’Dowd, D. K., Hagerman, R. J., Ono, M. Y., Hessl, D. R., et al. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0073 · Cited by 33
Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling
Yadav, P., Selvaraj, B. T., Bender, F. L. P., Behringer, M., Moradi, M., Sivadasan, R., Dombert, B., Blum, R., Asan, E., Sauer, M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1564-y · Cited by 33
“Neurofilaments modulate microtubule stability and thus axon caliber and microtubule functions in axonal transport [49].”
BackgroundSelf-citationPetrozziello, T., Amaral, A. C. S., Dujardin, S., Farhan, S. M. K., Chan, J. G. M., Trombetta, B. A., Kivisäkk, P., Mills, A. N., Bordt, E. A., Kim, S. E., et al. (2021) · Brain Pathology · doi:10.1111/bpa.13035 · Cited by 35
Purohit, P., Pérez‐Brangulí, F., Prots, I., Borger, E., Gunn, F. J., Welzel, O., Loy, K., Wenzel, E. M., Grömer, T. W., Brachs, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103976 · Cited by 36
“The idea of EFhd2 as a regulator of axonal transport is fully compatible with a possible function of EFhd2 in establishing and breaking down contacts between pre- and post-synaptic membrane structures [11].”
BackgroundInfluentialEffects of mild running on substantia nigra during early neurodegeneration
de Almeida, M. F., Silva, C. M., Chaves, R. S., Lima, N. C. R., Almeida, R. S., de Melo, K. P., Demasi, M., Fernandes, T. M., de Oliveira, E. M., Netto, L. E. S., et al. (2017) · Journal of Sports Sciences · doi:10.1080/02640414.2017.1378494 · Cited by 34
“…Akaravichien, Kukongviriyapan, & Sattayasai, 2015; Uttara, Singh, Zamboni, & Mahajan, 2009); disruption on axonal transport (Goldstein, 2012; Millecamps & Julien, 2013); and neurotrophic factors pathways (Berghauzen-Maciejewska et al., 2015; Mariani et al., 2015; van der Kolk et al., 2015),…”
Xue, C., Shtylla, B., & Brown, A. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004406 · Cited by 34
“31 These accumulations are thought to be caused by alterations in neurofilament transport, but the 32 mechanism is not understood [35–40].”
BackgroundNian, F., Li, L.-L., Cheng, C.-Y., Wu, P.-C., Lin, Y.-T., Tang, C.-Y., Ren, B.-S., Tai, C., Fann, M., Kao, L., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1471-z · Cited by 35
JIP3 links lysosome transport to regulation of multiple components of the axonal cytoskeleton
Rafiq, N. M., Lyons, L. L., Gowrishankar, S., Camilli, P. V. D., & Ferguson, S. M. (2022) · Communications Biology · doi:10.1038/s42003-021-02945-x · Cited by 33
“These challenges create unique vulnerabilities that are reflected in the numerous neurodevelopmental and neurodegenerative diseases arising from defects in axonal transport and maintenance (Coleman and Hoke, 2020; Millecamps and Julien, 2013; Sleigh et al., 2019).”
BackgroundMicrotechnologies to fuel neurobiological research with nanometer precision
Brunello, C. A., Jokinen, V. P., Sakha, P., Terazono, H., Nomura, F., Kaneko, T., Lauri, S. E., Franssila, S., Rivera, C., Yasuda, K., et al. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-11 · Cited by 31
“Defects in axonal transport play an important role in pathogenesis of neurodegenerative diseases [36].”
BackgroundThe GRIP1/14-3-3 Pathway Coordinates Cargo Trafficking and Dendrite Development
Geiger, J. C., Lipka, J., Segura, I., Hoyer, S. C., Schlager, M. A., Wulf, P. S., Weinges, S., Demmers, J., Hoogenraad, C. C., & Acker‐Palmer, A. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.01.018 · Cited by 34
“Moreover, impairment of intracellular trafficking is detrimental to neurons and has emerged as a common factor in several neurological disorders (Franker and Hoogenraad, 2013; Millecamps and Julien, 2013).”
BackgroundAxonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo
Milde, S., Gilley, J., & Coleman, M. P. (2013) · BioArchitecture · doi:10.4161/bioa.27049 · Cited by 35
Adult Mouse Retina Explants: From ex vivo to in vivo Model of Central Nervous System Injuries
Schaeffer, J., Delpech, C., Albert, F., Belin, S., & Nawabi, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.599948 · Cited by 30
Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature
Wadan, A. S., Shaaban, A., El-Sadek, M. Z., Mostafa, S. A., Moshref, A. S., El‐Hussein, A., Ellakwa, D. E., & Mehanny, S. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04014-0 · Cited by 47
“Motor proteins, adaptor complexes, and signaling pathways tightly regulate mitochondrial transport in neurons (Table 3) (Hol-lenbeck and Saxton 2005; Millecamps and Julien 2013; Hung 2021).”
Selective synaptic targeting of the excitatory and inhibitory presynaptic organizers, FGF22 and FGF7
Terauchi, A., Timmons, K. M., Kikuma, K., Pechmann, Y., Kneussel, M., & Umemori, H. (2014) · Journal of Cell Science · doi:10.1242/jcs.158337 · Cited by 32
“The tail region of KIFs interacts with adaptor proteins, which recognize cargos containing specific molecules to be transported (Hirokawa et al., 2010; Hirokawa et al., 2009; Kardon and Vale, 2009; Millecamps and Julien, 2013).”
BackgroundCargos Rotate at Microtubule Intersections during Intracellular Trafficking
Gao, Y., Anthony, S. M., Yu, Y., Yi, Y., & Yu, Y. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.05.010 · Cited by 28
Fell, S. M., Li, S., Wallis, K., Kock, A., Surova, O. V., Rraklli, V., Höfig, C. S., Li, W., Mittag, J., Arsenian‐Henriksson, M., et al. (2017) · Genes & Development · doi:10.1101/gad.297077.117 · Cited by 28
“MASH1, PHOX2A, GATA3, andHAND2 are all required for normal development and differentiation of sympathetic neurons in vivo, as indicated bymouse knockout models (Guillemot et al. 1993; Morin et al. 1997; Morikawa et al. 2007).”
BackgroundWu, G., Shanmugam, M. M., Bhan, P., Huang, Y., & Wagner, O. I. (2016) · Traffic · doi:10.1111/tra.12413 · Cited by 31
“In contrast, the retrograde motor cytoplasmic dynein moves cargo (such as recycled synaptic vesicles) from the plus-ends to the minus-ends of microtubules (1,2).”
Multiple roles for the cytoskeleton in ALS
Liu, X., & Henty-Ridilla, J. L. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114143 · Cited by 32
“normal development, is present in cells besides those affected by ALS, and with the exception of ALS2, is inherited in a dominant manner (Table 1) [22, 40, 41].”
BackgroundMixed pathology as a rule, not exception: Time to reconsider disease nosology
Chu, Y., Hirst, W. D., & Kordower, J. H. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85538-9.00012-2 · Cited by 29
Soustelle, L., Aimond, F., López-Andrés, C., Brugioti, V., Raoul, C., & Layalle, S. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0562-23.2023 · Cited by 30
Tao, F., Beecham, G. W., Rebelo, A. P., Blanton, S. H., Moran, J. J. M., Lopez‐Anido, C., Svaren, J. P., Abreu, L., Rizzo, D. N., Kirk, C. A., et al. (2019) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-190377 · Cited by 28
“Microtubules are part of the cytoskeleton and are involved in many cellular processes such as intracellular transport in axons [15].”
BackgroundAdvancements and challenges in amyotrophic lateral sclerosis
Bradford, D. R., & Rodgers, K. E. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1401706 · Cited by 38
Mukherjee, R., Majumder, P., & Chakrabarti, O. (2017) · Traffic · doi:10.1111/tra.12527 · Cited by 29
“Ubiquitination of motor proteins and adaptors also regulate transport of cargo.(5,16,47) These mechanisms are necessary to finetune the mode of cargo transport depending on external cues like other signaling cascades and may render specificity to this process.”
BackgroundHitching a Ride: Mechanics of Transport Initiation through Linker-Mediated Hitchhiking
Mogre, S. S., Christensen, J. R., Niman, C. S., Reck‐Peterson, S. L., & Koslover, E. F. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.01.024 · Cited by 24
Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis
Yousefian-Jazi, A., Seol, Y., Kim, J., Ryu, H. L., Lee, J.-H., & Ryu, H. (2020) · Cells · doi:10.3390/cells9122687 · Cited by 35
Abouward, R., & Schiavo, G. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03724-3 · Cited by 30
Petyuk, V., Yu, L., Olson, H. M., Yu, F., Clair, G., Qian, W., Shulman, J. M., & Bennett, D. A. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00747 · Cited by 29
Li, A., & Zhang, Y. J. (2022) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2022.115757 · Cited by 35
Lefebvre-Omar, C., Liu, E., Dalle, C., d’Incamps, B. L., Bigou, S., Daube, C., Karpf, L., Davenne, M., Robil, N., Jost-Mousseau, C., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04797-6 · Cited by 30
Self-citation
Metadata
- Authors
- Millecamps, S., & Julien, J.-P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Centre hospitalier universitaire de Québec (CA)
- Corresponding author
- Julien, Jean-Pierre
- Venue
- Nature Reviews Neuroscience
- Published
- 2013-01-30
- Volume
- 14
- Issue
- 3
- Pages
- 161-176
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2006524711
- Cited by
- 755
- References
- 180
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 46 · 2023: 51 · 2022: 70 · 2021: 57 · 2020: 61 · 2019: 60 · 2018: 60 · 2017: 67 · 2016: 79 · 2015: 63 · 2014: 45 · 2013: 22
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- axonal transport, neurodegenerative diseases, microtubule transport, anterograde transport, retrograde transport, mitochondrial transport, protein aggregate clearance, synapse maintenance, pathogenesis
- MeSH terms
- Animals, Axonal Transport, Humans, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.